BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37955603)

  • 1. Discovery of dual-target natural inhibitors of meprins α and β metalloproteases for inflammation regulation: pharmacophore modelling, molecular docking, ADME prediction, and molecular dynamics studies.
    Eltaib L; Alzain AA
    SAR QSAR Environ Res; 2023 Nov; ():1-23. PubMed ID: 37955603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights from Analysis of Binding Sites of Human Meprins: Screening of Inhibitors by Molecular Dynamics Simulation Study.
    Chaudhuri A; Bera AK; Sarkar I; Chakraborty S
    Comb Chem High Throughput Screen; 2016; 19(3):246-58. PubMed ID: 26875789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannan-binding protein blocks the activation of metalloproteases meprin alpha and beta.
    Hirano M; Ma BY; Kawasaki N; Okimura K; Baba M; Nakagawa T; Miwa K; Kawasaki N; Oka S; Kawasaki T
    J Immunol; 2005 Sep; 175(5):3177-85. PubMed ID: 16116208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring protein-protein intermolecular recognition between meprin-α and endogenous protease regulator cystatinC coupled with pharmacophore elucidation.
    Chaudhuri A; Biswas S; Chakraborty S
    J Biomol Struct Dyn; 2019 Feb; 37(2):440-453. PubMed ID: 29343185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of dual-target natural antimalarial agents against DHODH and PMT of
    Elamin EM; Eshage SE; Mohmmode SM; Mukhtar RM; Mahjoub M; Sadelin E; Shoaib TH; Edris A; Elshamly EM; Makki AA; Ashour A; Sherif AE; Osman W; Ibrahim SRM; Mohamed GA; Alzain AA
    SAR QSAR Environ Res; 2023; 34(9):709-728. PubMed ID: 37665563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of meprin metalloproteinases in cytokine processing and inflammation.
    Herzog C; Haun RS; Kaushal GP
    Cytokine; 2019 Feb; 114():18-25. PubMed ID: 30580156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel natural products as dual MNK/PIM inhibitors for acute myeloid leukemia treatment: Pharmacophore modeling, molecular docking, and molecular dynamics studies.
    Mohamed LM; Eltigani MM; Abdallah MH; Ghaboosh H; Bin Jardan YA; Yusuf O; Elsaman T; Mohamed MA; Alzain AA
    Front Chem; 2022; 10():975191. PubMed ID: 35936081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Studies.
    AbdElmoniem N; H Abdallah M; M Mukhtar R; Moutasim F; Rafie Ahmed A; Edris A; Ibraheem W; Makki AA; M Elshamly E; Elhag R; Osman W; A Mothana R; Alzain AA
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore modeling coupled with molecular dynamic simulation approach to identify new leads for meprin-β metalloprotease.
    Chaudhuri A; Hudait N; Chakraborty SS
    Comput Biol Chem; 2019 Jun; 80():292-306. PubMed ID: 31054542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: pharmacophore modeling, molecular docking, MM-GBSA calculations and molecular dynamics studies.
    Alzain AA; Elbadwi FA; Shoaib TH; Sherif AE; Osman W; Ashour A; Mohamed GA; Ibrahim SRM; Roh EJ; Hassan AHE
    Front Chem; 2024; 12():1339891. PubMed ID: 38318109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metalloproteases meprin α and meprin β: unique enzymes in inflammation, neurodegeneration, cancer and fibrosis.
    Broder C; Becker-Pauly C
    Biochem J; 2013 Mar; 450(2):253-64. PubMed ID: 23410038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
    Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
    J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring natural products as multi-target-directed drugs for Parkinson's disease: an
    Boulaamane Y; Touati I; Goyal N; Chandra A; Kori L; Ibrahim MAA; Britel MR; Maurady A
    J Biomol Struct Dyn; 2023 Sep; ():1-18. PubMed ID: 37753798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore-based virtual screening, molecular docking and molecular dynamics simulations study for the identification of LIM kinase-1 inhibitors.
    Singh R; Pokle AV; Ghosh P; Ganeshpurkar A; Swetha R; Singh SK; Kumar A
    J Biomol Struct Dyn; 2023; 41(13):6089-6103. PubMed ID: 35862656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meprin metalloproteases: Molecular regulation and function in inflammation and fibrosis.
    Arnold P; Otte A; Becker-Pauly C
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2096-2104. PubMed ID: 28502593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mPGES-1 Inhibitor Discovery Based on Computer-Aided Screening: Pharmacophore Models, Molecular Docking, ADMET, and MD Simulations.
    Huang Q; Lai T; Wang Q; Luo L
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of pyrazole-based inhibitors of meprin α and β.
    Tan K; Jäger C; Geissler S; Schlenzig D; Buchholz M; Ramsbeck D
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2165648. PubMed ID: 36661029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches.
    Rehman HM; Sajjad M; Ali MA; Gul R; Naveed M; Aslam MS; Shinwari K; Bhinder MA; Ghani MU; Saleem M; Rather MA; Ahmad I; Amin A
    Int J Biol Macromol; 2023 May; 237():124169. PubMed ID: 36990409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.